These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22690855)

  • 1. Effects of linseeds on the symptoms of irritable bowel syndrome: a pilot randomised controlled trial.
    Cockerell KM; Watkins AS; Reeves LB; Goddard L; Lomer MC
    J Hum Nutr Diet; 2012 Oct; 25(5):435-43. PubMed ID: 22690855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
    Tack JF; Miner PB; Fischer L; Harris MS
    Aliment Pharmacol Ther; 2011 Oct; 34(8):868-77. PubMed ID: 21883322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.
    Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Simrén M
    Gastroenterology; 2015 Nov; 149(6):1399-1407.e2. PubMed ID: 26255043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
    Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.
    Ong DK; Mitchell SB; Barrett JS; Shepherd SJ; Irving PM; Biesiekierski JR; Smith S; Gibson PR; Muir JG
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1366-73. PubMed ID: 20659225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopathy improves the severity of irritable bowel syndrome: a pilot randomized sham-controlled study.
    Florance BM; Frin G; Dainese R; Nébot-Vivinus MH; Marine Barjoan E; Marjoux S; Laurens JP; Payrouse JL; Hébuterne X; Piche T
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):944-9. PubMed ID: 22546751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study.
    Brennan BP; Fogarty KV; Roberts JL; Reynolds KA; Pope HG; Hudson JI
    Hum Psychopharmacol; 2009 Jul; 24(5):423-8. PubMed ID: 19548294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
    Hawrelak JA; Myers SP
    J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
    Weinland SR; Morris CB; Hu Y; Leserman J; Bangdiwala SI; Drossman DA
    Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome.
    Mazzawi T; Hausken T; Gundersen D; El-Salhy M
    Mol Med Rep; 2013 Sep; 8(3):845-52. PubMed ID: 23820783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
    Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
    Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
    Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND; Grillage MG; Mazumder R; Atkinson SN
    Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
    Dolin BJ
    Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion.
    Anastasi JK; McMahon DJ; Kim GH
    Gastroenterol Nurs; 2009; 32(4):243-55. PubMed ID: 19696601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
    Lee KJ; Kim NY; Kwon JK; Huh KC; Lee OY; Lee JS; Choi SC; Sohn CI; Myung SJ; Park HJ; Choi MK; Bak YT; Rhee PL
    Neurogastroenterol Motil; 2011 Dec; 23(12):1098-104. PubMed ID: 21920001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.